Iris Dotan Selected Research

Pouchitis

1/2022	Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety.
1/2022	Reply to Antibiotic Use Patterns in the Management of Chronic Pouchitis.
1/2022	Fecal Calprotectin Is Increased in Pouchitis and Progressively Increases With More Severe Endoscopic and Histologic Disease.
3/2021	Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease.
1/2020	Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.
1/2020	Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study From the Porto Group of ESPGHAN.
12/2019	Faecal Proteases from Pouchitis Patients Activate Protease Activating Receptor-2 to Disrupt the Epithelial Barrier.
1/2019	Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.
1/2018	Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.
9/2015	Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iris Dotan Research Topics

Disease

43	Ulcerative Colitis 06/2022 - 05/2005
41	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 05/2004
34	Crohn Disease (Crohn's Disease) 11/2022 - 05/2005
24	Inflammation (Inflammations) 03/2021 - 04/2005
14	Pouchitis 01/2022 - 01/2009
13	Infections 11/2022 - 11/2006
7	Neoplasms (Cancer) 06/2022 - 07/2006
6	Necrosis 06/2022 - 05/2015
4	Colitis 01/2018 - 01/2010
3	Disease Progression 01/2022 - 01/2009
2	COVID-19 02/2022 - 01/2022
2	Hemorrhage 01/2022 - 12/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2020
2	Breast Neoplasms (Breast Cancer) 09/2017 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 09/2010 - 07/2006
1	Wounds and Injuries (Trauma) 11/2022
1	Proctitis 11/2022
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 05/2022
1	Herpes Zoster 02/2022
1	Fatigue 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Thrombophilia 01/2022
1	Morbid Obesity 10/2021
1	Adenoma (Adenomas) 10/2021
1	Alopecia (Baldness) 01/2021
1	Metaplasia 01/2021
1	Dermatitis 01/2021
1	Viremia 11/2020
1	Clostridium Infections 01/2019
1	Rheumatoid Arthritis 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

12	AntibodiesIBA 01/2022 - 08/2006
9	C-Reactive ProteinIBA 01/2022 - 01/2006
9	Infliximab (Remicade)FDA Link 01/2022 - 08/2005
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2006
6	Pharmaceutical PreparationsIBA 11/2022 - 11/2012
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2015
6	vedolizumabIBA 01/2022 - 01/2017
6	Capsules (Microcapsules)IBA 01/2019 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2007
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 03/2015
5	Polysaccharides (Glycans)IBA 01/2019 - 08/2006
4	Immunologic Factors (Immunomodulators)IBA 02/2022 - 08/2013
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2020
3	etrolizumabIBA 01/2022 - 07/2014
3	VaccinesIBA 01/2022 - 02/2012
3	Adalimumab (Humira)FDA Link 01/2022 - 03/2015
3	IntegrinsIBA 01/2020 - 02/2016
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
3	SteroidsIBA 01/2017 - 08/2013
3	AntigensIBA 02/2015 - 01/2010
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022 - 02/2012
2	tofacitinibIBA 02/2022 - 01/2022
2	Biological ProductsIBA 01/2022 - 01/2009
2	EnzymesIBA 03/2021 - 08/2006
2	Proton Pump InhibitorsIBA 01/2021 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 12/2019 - 07/2015
2	Budesonide (Pulmicort)FDA LinkGeneric 11/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 09/2017 - 05/2004
2	Monoclonal AntibodiesIBA 01/2017 - 02/2016
2	CarbohydratesIBA 10/2015 - 08/2006
2	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2013 - 09/2011
2	CytokinesIBA 06/2010 - 11/2006
2	Fibrinogen (Factor I)FDA Link 12/2008 - 04/2005
1	vinyltriethoxysilane (VTES)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 12/2021
1	UreaseIBA 12/2021
1	Bile Acids and Salts (Bile Acids)IBA 03/2021
1	MucinsIBA 03/2021
1	Glycoside Hydrolases (Endoglycosidases)IBA 03/2021
1	Amino Acids FDA Link 03/2021
1	Butyrates (Butyrate)IBA 03/2021
1	colibactinIBA 11/2020
1	Biological FactorsIBA 11/2020
1	GuaiacIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Ustekinumab (CNTO 1275)FDA Link 01/2020
1	Tight Junction ProteinsIBA 12/2019
1	Urea (Carbamide)FDA LinkGeneric 02/2019
1	MacrolidesIBA 01/2019

Therapy/Procedure

26	Therapeutics 11/2022 - 11/2004
15	Restorative Proctocolectomy 01/2022 - 08/2008
7	Remission Induction 01/2022 - 10/2013
5	Colectomy 06/2022 - 01/2017
2	Bariatric Surgery 05/2022 - 10/2021
2	Ileostomy 01/2017 - 06/2010
1	Gastrectomy 05/2022
1	Immunomodulation 02/2022
1	Enteral Nutrition (Feeding, Tube) 01/2022
1	Colonic Pouches (S Pouch) 01/2022
1	Fecal Microbiota Transplantation 01/2019
1	Heart-Assist Devices 12/2018